Published in Arch Int Pharmacodyn Ther on June 01, 1970
A comparison of the vascular dopamine receptor with other dopamine receptors. Annu Rev Pharmacol Toxicol (1978) 1.41
Dissociation of potentiation of isoprenaline by cocaine from inhibition of uptake in cat spleen. Br J Pharmacol (1970) 1.08
Selective DA2 versus DA1 antagonist activity of domperidone in the periphery. Eur J Pharmacol (1983) 1.07
Altered norepinephrine turnover and metabolism in diabetic cardiomyopathy. Circ Res (1986) 1.02
Norepinephrine storage, distribution, and release in diabetic cardiomyopathy. Am J Physiol (1987) 1.02
Excitatory action of sympathomimetic amines on 5-hydroxytryptamine receptors of gut. Br J Pharmacol (1969) 1.01
Peripheral pre- and post-synaptic dopamine receptors: are they different from dopamine receptors in the central nervous system? Commun Psychopharmacol (1979) 1.00
Pathogenesis of cardiac dysfunction in diabetes mellitus. Can J Cardiol (1985) 0.98
Adrenoceptive receptors in the duodenum, aorta and atria of the rabbit. J Pharm Pharmacol (1967) 0.92
Regional variation in the alpha-adrenergic receptors in the canine resistance vessels. Naunyn Schmiedebergs Arch Pharmacol (1982) 0.92
2,3-Dihydroxy-9-amino-9,10-dihydrophenanthrene, a rigid congener of dopamine and isoapomorphine. J Med Chem (1978) 0.91
Characteristics of the vascular dopamine receptor: comparison with other receptors. Fed Proc (1978) 0.91
Absorption and excretion of 2,4-dichlorophenoxyacetic acid in man. Xenobiotica (1974) 0.90
Characterization of insulin receptors in cardiac sarcolemmal and sarcoplasmic reticular membranes. J Cardiovasc Pharmacol (1987) 0.88
A comparative study of dopamine and noradrenaline on the rabbit aorta. Can J Physiol Pharmacol (1969) 0.88
Protection against induction of supersensitivity to catecholamines by cocaine. Br J Pharmacol (1971) 0.87
Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390. Hypertension (1984) 0.86
Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog. J Pharmacol Exp Ther (1987) 0.86
Norepinephrine on venous compliance and unstressed volume in cat liver. Am J Physiol (1985) 0.86
Cardiovascular effects of (--)-cathinone in the anaesthetized dog: comparison with (+)-amphetamine. J Pharm Pharmacol (1982) 0.86
Responses of contractile function to ruthenium red in rat heart. Am J Physiol (1988) 0.85
Alpha-adrenergic blocking action of propranolol. J Pharm Pharmacol (1967) 0.85
Structure activity relationships of N-substituted dopamine derivatives as agonists of the dopamine vascular and other cardiovascular receptors. J Pharmacol Exp Ther (1980) 0.85
Relative activities of SCH 23390 and its analogs in three tests for D1/DA1 dopamine receptor antagonism. Eur J Pharmacol (1986) 0.85
Lack of spare -adrenoceptors in cat spleen. Can J Physiol Pharmacol (1972) 0.84
Dopamine agonist properties of N-alkyl-4-(3,4-dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinolines. J Med Chem (1981) 0.84
Effect of cocaine on the affinity of -adrenoceptors for noradrenaline. Br J Pharmacol (1973) 0.83
Alpha-adrenoceptor blocking activity of fenoldopam (SK&F 82526), a selective DA1 agonist. J Pharm Pharmacol (1986) 0.83
Venoconstriction of hepatic capacitance vessels during hemorrhage in cats: afferent mechanisms. Am J Physiol (1994) 0.82
Reduction in the severity of myocardial infarction by sulfinpyrazone. Am Heart J (1981) 0.82
Further observations on mesenteric vasoconstriction, survival and the clotting defect after endotoxin administration. Br J Pharmacol (1973) 0.81
Receptors for sympathomimetic amines in the rabbit aorta: differentiation by specific antagonists. Br J Pharmacol Chemother (1968) 0.81
Sulpiride: a weak antagonist of norepinephrine and 5-hydroxytryptamine. Eur J Pharmacol (1979) 0.81
Antagonism of prostanoid-induced vascular contraction by 13-azaprostanoic acid (13-APA). J Cardiovasc Pharmacol (1984) 0.81
Utilization of calcium pools during pharmaco or electromechanical coupling in smooth muscle. Can J Physiol Pharmacol (1975) 0.80
N,N-Di-n-propyl dopamine: a qualitatively different dopamine vascular agonist. J Pharmacol Exp Ther (1978) 0.80
Comparison of the cardiovascular actions of dopamine and epinine in the dog. J Pharmacol Exp Ther (1985) 0.80
The role of bound calcium in supersensitivity induced by cocaine. Br J Pharmacol (1976) 0.79
Isoprenaline-induced relaxation of smooth muscle not due to electrogenic sodium pumping. Can J Physiol Pharmacol (1972) 0.79
Contractile actions of racemic and d-propranolol on isolated canine mesenteric and coronary arteries. J Pharmacol Exp Ther (1982) 0.78
Hypotensive effects of N,N-din-n-propylodopamine in the anesthetized dog: comparison with sodium nitroprusside. J Cardiovasc Pharmacol (1980) 0.78
Pathophysiological aspects of myocardial hypertrophy. Can J Cardiol (1987) 0.78
Specific dopamine D-1 and DA1 properties of 4-(mono- and -dihydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline and its tetrahydrothieno[2,3-c]pyridine analogue. J Med Chem (1987) 0.78
The role of sodium pump in the inhibition of smooth muscle responsiveness to agonists during potassium restoration. Br J Pharmacol (1973) 0.78
Changes in hepatic blood volume on galactose and indocyanine green uptake by cat liver. Am J Physiol (1989) 0.78
Effects of dopamine, N-N-di-n-propyl dopamine, and (R)- and (S)-sulpiride on guinea pig blood pressure. J Cardiovasc Pharmacol (1982) 0.78
Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog. J Pharmacol Exp Ther (1980) 0.77
Conformational requirements for dopamine-induced vasodilation. Proc Natl Acad Sci U S A (1977) 0.77
Effects of splanchnic nerve stimulation on cardiac preload, afterload, and output in cats. Circ Res (1980) 0.77
Influence of anesthetics and of arterial blood pressure on the functional refractory period of atrioventricular conduction. J Pharmacol Exp Ther (1966) 0.77
Alcohol feeding alters (3H)dopamine uptake into rat cortical and brain stem synaptosomes. Prog Biochem Pharmacol (1981) 0.76
Pharmacological characterization of the postsynaptic alpha-adrenoceptors in isolated canine mesenteric arteries and veins. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.76
Identification of the smooth muscle excitatory receptors for ergot alkaloids. Br J Pharmacol Chemother (1962) 0.75
Vascular relaxing activity and stability studies of 10,10-difluoro-13,14-dehydroprostacyclin. Proc Natl Acad Sci U S A (1980) 0.75
Influence of sodium pumping on smooth muscle contraction. Br J Pharmacol (1972) 0.75
Acute toxicity of Iomex--a petroleum weedicide. Bull Environ Contam Toxicol (1975) 0.75
Dermal absorption of fenitrothion in rat. Bull Environ Contam Toxicol (1974) 0.75
Effects of bromocryptine on hepatic blood volume responses to hepatic nerve stimulation in cats. Can J Physiol Pharmacol (1986) 0.75
Effects of arteriolar vasodilators on hepatic venous compliance and cardiac output in anesthetized cats. J Cardiovasc Pharmacol (1982) 0.75
Differential antagonism of postsynaptic (DA1) and presynaptic (DA2) peripheral dopamine receptors by substituted benzamides. Adv Biochem Psychopharmacol (1982) 0.75
Effects of the enantiomers of 3-PPP on DA1 and DA2 dopamine receptors in the dog. Eur J Pharmacol (1985) 0.75
Inhibitory effects of catecholamines in the paravertebral sympathetic ganglia of the anesthetized dog. Eur J Pharmacol (1990) 0.75
Consistent unmasking of dopamine-induced dilation of the canine femoral vascular bed. J Pharmacol Exp Ther (1980) 0.75
Medical research in Canada. Manit Med Rev (1966) 0.75
Catecholamine injections in canine paravertebral ganglia produce hypotension by neurogenic vasodilatation. Cardiologia (1990) 0.75
Potentiation by dopexamine of the cardiac responses to circulating and neuronally released norepinephrine: a possible mechanism for the therapeutic effects of the drug. J Cardiovasc Pharmacol (1989) 0.75
Modification of cardiovascular actions of 2-amino-5,6-dihydroxytetralin by N,N-di-n-propyl substitution. Eur J Pharmacol (1982) 0.75
Interactions between different prostaglandins and other relaxing agents on isolated vascular smooth muscle. Adv Prostaglandin Thromboxane Res (1980) 0.75
Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature. Eur J Pharmacol (1991) 0.75
Pre- and post-sinusoidal origin of hepatic exudate in anesthetized cats. Can J Physiol Pharmacol (1991) 0.75
Isolation of the sino-atrial node with veratramine. J Pharmacol Exp Ther (1979) 0.75
Similarities and differences of dopamine receptors in the renal vascular bed and elsewhere. Adv Biochem Psychopharmacol (1977) 0.75
Venoconstriction of hepatic capacitance vessels during hemorrhage in cats: efferent mechanisms. Am J Physiol (1994) 0.75
Bulbocapnine is not a selective DA1 receptor antagonist. J Pharm Pharmacol (1986) 0.75
Effect of carotid sinus baroreceptor reflex on responses to phenylephrine and nitroprusside in anesthetized cats. J Cardiovasc Pharmacol (1981) 0.75
Vascular smooth muscle activity of 7-oxa-13-prostynoic acid. Blood Vessels (1979) 0.75
Potassium and the recovery of splenic capsular smooth muscle after cold storage. Can J Physiol Pharmacol (1976) 0.75
Induction of rhythmicity in a normally quiescent smooth muscle. J Pharm Pharmacol (1974) 0.75
Studies on the functional role of alpha-adrenoceptors in the cardiac sympathetic ganglia of the dog. Life Sci (1992) 0.75
Dopamine vascular actions of N-substituted derivatives of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (ADTN). Eur J Pharmacol (1979) 0.75
Effects of nifedipine on hepatic blood volume in cats: indirect venoconstriction and absence of inhibition of postsynaptic alpha 2-adrenoceptor responses. Can J Physiol Pharmacol (1986) 0.75
Effect of ring fluorination of epinephrine on its cardiovascular adrenoceptor activities. Eur J Pharmacol (1990) 0.75
Facilitation of ganglionic transmission by sulpiride: evidence for an inhibitory role of dopamine in the canine sympathetic ganglion. J Pharmacol Exp Ther (1982) 0.75
Letter: Clindamycin for acne. JAMA (1976) 0.75
Studies on the location of catecholamine receptors in canine sympathetic ganglia. Eur J Pharmacol (1992) 0.75
Synthesis of 2-(alkylamino)-5,6- and -6,7-dihydroxy-3,4-dihydroquinazolines and evaluation as potential dopamine agonists. J Med Chem (1982) 0.75
Stable carbocyclic analog of thromboxane A2 as antagonist of prostaglandin receptors. Adv Prostaglandin Thromboxane Leukot Res (1983) 0.75
Identification and characterization of dopamine receptors in the cardiovascular system. Cardiologia (1987) 0.75
Relative contracting and relaxing potencies of a series of prostaglandins on isolated canine mesenteric artery strips. Prostaglandins (1981) 0.75
Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission. J Pharmacol Exp Ther (1989) 0.75
Effects of 3',4'-dihydroxynomifensine on the dopamine vascular receptor. J Pharm Pharmacol (1980) 0.75
Increased depletion of catecholamines by reserpine in immature cats. Can J Physiol Pharmacol (1972) 0.75
Conformational requirements for vascular alpha-adrenergic activity. Proc Soc Exp Biol Med (1978) 0.75
C(2)-Methylation abolishes DA1 dopamine agonist activity of 2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (6,7-ADTN): steric intolerance by the receptor. J Med Chem (1984) 0.75
Absorption and excretion of 2,4,5-trichlorophenoxy acetic acid in man. Arch Int Pharmacodyn Ther (1974) 0.75
Influence of sex hormones on parathion toxicity in rats: antiacetylcholinesterase activity of parathion and paraoxon in plasma, erythrocytes, and brain. J Toxicol Environ Health (1982) 0.75